Search Results

Your search for John Jakob, MD PhD matches 2 pages

Showing 1 - 2

By Ronald Piana / April 10, 2021

Towering Figure in Cancer Drug Development, José Baselga, MD, PhD, FASCO, Dies at Age 61

José Baselga, MD, PhD, FASCO, a global innovator in novel cancer therapeutics, led research efforts in his native country of Spain and in the United States, most notably as Physician-in-Chief at Memorial Sloan Kettering Cancer Center (MSK). “My moment of recognition as an oncologist came early,...

issues in oncology

By John Jakob, MD PhD / March 15, 2014

After Next-Generation Sequencing: Guiding Patients to the Right Treatment

In the near future, community oncologists will be tasked with helping patients interpret the results of next-generation sequencing of their tumors. Specifically, we will help patients choose an academic center with a phase I targeted therapy program that is a plausible fit for their disease....

Apr

Today In Oncology

Search Results

Your search for John Jakob, MD PhD matches 2 pages

Towering Figure in Cancer Drug Development, José Baselga, MD, PhD, FASCO, Dies at Age 61

After Next-Generation Sequencing: Guiding Patients to the Right Treatment

Adjuvant Pembrolizumab in Renal Cell Carcinoma: Overall Survival in KEYNOTE-564

Combined ICI and VEGF Inhibitor Trials in Cancer Cardiovascular Eligibility Criteria and Adverse Event Reporting

Risk of T-Cell and Second Primary Malignant Neoplasms After CAR T-Cell Therapy

Lack of Research Focused on Older Adults With Cancer May Be Contributing to Disparities in Care

Breast Cancer Survivors: Relationship Satisfaction and Emotional and Physical Well-Being